Supply of Drugs and Medicines for Dr. Ruth K.M. Pfau Civil Hospital Karachi FY 2025-2026

This tender invites bids for the supply of drugs and medicines at Dr. Ruth K.M. Pfau Civil Hospital Karachi, Sindh. The procurement is managed by the hospital's Medical Superintendent and falls under the Pharmaceuticals & Laboratory Supplies category. The tender is open for the financial year 2025-2026 and aims to ensure the hospital is stocked with essential medicines to meet patient needs in Karachi. The scope covers the supply of various drugs and medicines as per the hospital's requirements. Bidders must obtain tender documents from the Procurement Department located on the 1st Floor of the Admin Block at Dr. Ruth K.M. Pfau Civil Hospital. The tender follows a single stage, one envelope procedure under SPP Rule 46(1). The estimated cost is approximately PKR 2.995 million. The hospital requires bidders to submit samples free of cost and attach a bid security of 2.5% of the quoted price. Delivery and inspection will be conducted at the hospital's medical and general stores. Bidders should ensure compliance with PEC categories relevant to pharmaceuticals and maintain valid FBR/ATL status. The tender requires submission of GST/NTN certificates, valid drug licenses, and financial turnover proof of at least PKR 100 million for the last three years. The bid validity is 90 days, and performance security of 5% of the contract value is mandatory. All government taxes and stamp duties must be included in the quoted rates. The submission deadline is set for 24th February 2026, between 11:00 a.m. and 12:00 noon, with bid opening at 12:30 p.m. at the Committee Room on the 2nd Floor of the Admin Block, Baba e Urdu Road, Karachi. Tender purchase receipts costing PKR 2,000 are non-refundable and must be attached with the bid. Pro-Tip: Carefully review the tender documents for the required bid security format and ensure all pages are signed and stamped. Missing or incomplete documentation is a common cause for rejection, so pay close attention to the technical evaluation criteria and sample submission deadlines.